Calendar BioVie Inc.

Equities

BIVI

US09074F2074

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
0.4848 USD -0.84% Intraday chart for BioVie Inc. -0.35% -61.52%

Chart calendar BioVie Inc.

af0985c540b8a4684e877ebdee3815f.HuwrxnMCELnjIw6Bp1dRd1exdDDaEVs9X6WZFulanJg.XLxBjiBXd_SqeWexzQVjISfWE3iRfjxXCJPKUbobqv5yuWPyS0hniI5IfQ~568176b835f927e9f283c6bc3a4f0d0a

Upcoming events on BioVie Inc.

10/05/2024 Q3 2024 Earnings Release (Projected)
13/05/2024 Q1 2025 Earnings Release (Projected)

Past events on BioVie Inc.

10/04/2024 RedChip Investor Group Call
09/03/2024 08:40 pm Alzheimer and Parkinson Diseases International Conference
08/03/2024 08:20 pm Alzheimer and Parkinson Diseases International Conference
14/02/2024 11:10 pm Oppenheimer Healthcare Life Sciences Conference
29/11/2023 07:00 pm NE3107 Phase 3 Trial Results Call
13/11/2023 11:30 pm American Association for the Study of Liver Diseases Conference
08/11/2023 11:30 pm Annual General Meeting
01/11/2023 05:30 pm Business Update Call
25/10/2023 10:00 pm Clinical Trials on Alzheimer Disease Conference
26/09/2023 08:00 pm Cantor Global Healthcare Conference
11/09/2023 American Neurological Association meeting
08/09/2023 12:00 am Investor Meeting - Key Opinion Leader
16/07/2023 12:15 pm Alzheimer Associate International Conference
25/06/2023 12:00 am American Diabetes Association Scientific Session - Poster: #1520
12/05/2023 Q3 2023 Earnings Release
25/04/2023 09:15 pm American Academy of Neurology Meeting - Kaya Jordan
25/04/2023 05:30 pm American Academy of Neurology Meeting - Joseph Palumbo
23/04/2023 05:30 pm American Academy of Neurology Meeting - Nilab Osman
01/04/2023 07:30 pm Alzheimer & Parkinson Disease International Conference
28/03/2023 Alzheimer & Parkinson Disease International Conference

Annual results

Fiscal PeriodJune 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-2,69


-138
-43,5
-217.37%
-27,3
-26,6
-2.35%
-45,1
-47,7
5.58%

-48,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-130
-35,8
-263.82%
-26,1
-28,3
7.7%
-50,3
-55,4
9.27%

-49,4

Net income
Million USD
Released
Forecast
Spread
0,00


-184
-89,4
-105.65%
-26,1
-27,4
4.87%
-50,3
-55,4
9.27%

-49,4

EPS
USD
Released
Forecast
Spread
-6,85


-14,8
-7,18
-106.41%
-1,06
-1,12
5.57%
-1,55
-1,76
11.93%

-1,02

Announcement Date06/08/2030/08/2127/09/2216/08/23-

Quarterly results

Fiscal PeriodJune 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-6,67
-10,3
35.29%
-5,75
-7,87
26.98%
-9,29
-9,56
2.84%
-8,83
-6,45
-37.07%
-11,5
-9,02
-27.48%
-13,8
-9,90
-39.21%
-11,0
-13,6
19.52%



-8,78
-11,4
22.91%

-12,6


-13,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,41
-10,9
50.33%
-7,04
-8,18
13.91%
-8,09
-10,3
21.19%
-10,4
-6,84
-52.32%
-15,7
-9,78
-60.36%
-15,0
-11,7
-28.3%
-9,11
-14,2
36.03%



-8,40
-11,9
29.42%

-12,9


-13,7

Net income
Million USD
Released
Forecast
Spread
-5,41
-10,9
50.33%
-7,04
-8,18
13.91%
-8,09
-9,42
14.15%
-10,4
-6,84
-52.32%
-15,7
-9,78
-60.36%
-15,0
-11,7
-28.3%
-9,11
-14,2
36.03%



-8,40
-11,9
29.42%

-12,9


-13,7

EPS
USD
Released
Forecast
Spread
-0,22
-0,41
46.34%
-0,28
-0,28
0%
-0,33
-0,37
11.41%
-0,38
-0,29
-33.33%
-0,50
-0,25
-98.02%
-0,43
-0,36
-21.13%
-0,23
-0,40
42.5%
-0,29
-0,31
6.45%
-0,22
-0,28
20%

-0,25


-0,26

Announcement Date08/02/2211/05/2227/09/2204/11/2210/02/2312/05/2316/08/2308/11/2313/02/24--

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise